Search
Showing results for "1"
Research
Prenatal omega-3 LCPUFA and symptoms of allergic disease and sensitization throughout early childhoodMaternal supplementation with 900 mg of ω-3 LCPUFA did not change the progression of IgE-mediated allergic disease symptoms or sensitization
News & Events
Would you like to test our new exercise app?We have been working with young people with T1D, other researchers and app developers to create a new smartphone exercise app called acT1ve.
News & Events
Diabetes service celebrates 50th yearIt’s hard to believe that 20 years has passed since April Welsh, 5, was pictured with Professor Tim Jones in a story about type 1 diabetes research. Plenty has changed but one constant remains — Professor Jones still works for WA’s only paediatric diabetes service which celebrates its 50th year.
The WAACHS regional profiles look at all four volumes of results across the ATSIC regions of Western Australia.
Research
Interchangeability, immunogenicity and safety of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (Synflorix) and 13-valent-PCV (Prevenar13) schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trialAboriginal children living in remote communities are at high risk of early and persistent otitis media. Streptococcus pneumoniae and non-typeable Haemophilus influenzae (NTHi) are primary pathogens. Vaccines with potential to prevent early OM have not been evaluated in this population. We compared immunogenicity (ELISA and opsonophagocytic activity) of a combination of Synflorix™ (PHiD-CV10, 10 serotypes and protein D of NTHi) and Prevenar13™ (PCV13, 10 serotypes plus 3, 6A, and 19A), with recommended schedules.
Research
Vector fields of risk: A new approach to the geographical representation of childhood asthmaOne of the major challenges in health studies with a spatial dimension is to produce valid and meaningful geographical representations of risk.
News & Events
Oscar Hogan - How my brother living with T1D influenced my careerWe spoke to Oscar and asked him to share his story about the challenges he faces when trying to support his brother, joining the Centre as a student and what T1D research means to him, his brother and his family.
News & Events
Crippa's Footy ClinicDiabetes Research Western Australia (DRWA) are inviting children aged 6-16 living with type 1 and type 2 diabetes to join West Coast Eagles forward Jamie Cripps for a fun-filled footy clinic.
News & Events
Should I send my child to school?With Term 2 commencing this week, many parents are unsure as to whether to send their child with type 1 diabetes back to school. To assist parents with their own decision-making process, it is important to consider the individual risks and benefits for each family.
Research
"i Think i Could Have Used It Better": Experiences of Youth with High HbA1c Commencing Advanced Hybrid Closed-Loop Therapy in a Clinical Trial Setting - A Qualitative ResearchAdvanced hybrid closed-loop (AHCL) therapy improves glycemia. However, it is not known if there is an improvement in overall outcomes with AHCL for youth with type 1 diabetes (T1D) at high risk of diabetes-related complications. The study aimed to capture the experiences of youth with suboptimal glycemic control when commencing AHCL therapy in a clinical trial setting.